# A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma

> **NCT00384189** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1080 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Placebo
- **DRUG:** Salbutamol

## Key facts

- **NCT ID:** NCT00384189
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-08
- **Final completion:** 2008-08
- **Target enrollment:** 1080 (ACTUAL)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384189, "A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00384189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
